NASDAQ:KROS

Keros Therapeutics Stock Forecast

etoro logo Buy KROS
*Your capital is at risk
$10.61
-0.420 (-3.81%)
At Close: Jul 16, 2026
AI Analysis AI Analysis of KROS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KROS to Watchlist?
Some Reasons Why To Add KROS:
  • High gross margin of 96.5%
  • Low bankruptcy risk (Altman Z-Score: 5.78)
  • Highly efficient cash conversion (102% FCF/OCF ratio)
PDF

Evaluation of Keros Therapeutics Inc. stock downgraded after the last trading session
(Updated on Jul 16, 2026)

Sell candidate since Jul 16, 2026

The Keros Therapeutics Inc. stock price fell by -3.81% on the last day (Thursday, 16th Jul 2026) from $11.03 to $10.61. During the last trading day the stock fluctuated 5.96% from a day low at $10.41 to a day high of $11.03. The price has been going up and down for this period, and there has been a -2.48% loss for the last 2 weeks. Volume has increased on the last day by 53 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 247 thousand shares were bought and sold for approximately $2.62 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.34% during the next 3 months and, with a 90% probability hold a price between $8.97 and $11.34 at the end of this 3-month period.

KROS Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 14, 2026, and so far it has risen 0.378%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Keros Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $11.26 and $10.80. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Wednesday, June 10, 2026 and based on theory for this formation the price should go up by 15.42% to $12.25 within 15 trading days (Thursday, July 02, 2026) since signal was issued.

Support, Risk & Stop-loss for Keros Therapeutics Inc. stock

Keros Therapeutics Inc. finds support from accumulated volume at $10.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.620 between high and low, or 5.96%. For the last week, the stock has had daily average volatility of 6.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KROS) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Keros Therapeutics Inc. to open at $10.68, and during the day (based on 14 day Average True Range), to move between $10.32 and $10.90, which gives a possible trading interval of +/-$0.583 (+/-5.65%) up or down from last closing price. If Keros Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.50 (1.04%) than the resistance at $10.98 (3.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Keros Therapeutics Inc. stock A Buy?

Keros Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.192 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $10.68 ( 0.691%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KROS Performance

Trading levels for KROS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 11.30 6.53%
R2 11.07 4.30%
R1 10.92 2.92%
Price 10.61
S1 10.45 -1.54%
S2 10.30 -2.92%
S3 10.06 -5.15%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.67 9.99%
R2 10.99 3.58%
R1 10.98 3.49%
Price 10.61
S1 10.50 -1.04%
S2 10.41 -1.89%
S3 9.91 -6.60%

FAQ

What is the symbol for Keros Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Keros Therapeutics Inc. is KROS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Keros Therapeutics Inc. Stock.

What's the current price of Keros Therapeutics Inc. Stock?
As of the end of day on the Jul 16, 2026, the price of an Keros Therapeutics Inc. (KROS) share was $10.61.

What is the 52-week high and low for Keros Therapeutics Inc. Stock?
The 52-week high for Keros Therapeutics Inc. Stock is $22.55 and the 52-week low is $9.69.

What is the market capitalization of Keros Therapeutics Inc. Stock?
As of the Jul 16, 2026, the market capitalization of Keros Therapeutics Inc. is 339.5M.

When is the next earnings date for Keros Therapeutics Inc.?
The upcoming earnings date for Keros Therapeutics Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT KEROS THERAPEUTICS INC.
Keros Therapeutics
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE